Literature DB >> 10522656

Role of transurethral resection of the prostate in population-based prostate cancer incidence rates.

R M Merrill1, E J Feuer, J L Warren, N Schussler, R A Stephenson.   

Abstract

The extensive pool of asymptomatic prostate disease in the population, which increases substantially with age, suggests that the frequent use of transurethral resection of the prostate (TURP) in recent decades has had a large effect on prostate cancer incidence. The authors identified the effect of TURP-detected prostate cancer on the observed incidence rates between 1973 and 1993 for men aged 65 years and older. They linked population-based cancer registry data from the Surveillance, Epidemiology, and End Results Program to Medicare records between 1986 and 1993 to determine whether a TURP occurred sufficiently close to the time of a prostate cancer diagnosis for them to assume that it led to the diagnosis. TURP-detected cases prior to 1986 were calculated using an indirect method that involved multiplying the TURP procedure rate in the general population (from the National Hospital Discharge Survey) by estimates of the proportion of TURPs resulting in a prostate cancer diagnosis (from Medicare data and the literature). TURP explained much of the observed increase in overall prostate cancer incidence between 1973 and 1986 and possibly all of it in men aged 70 years and older. However, its influence on the trend and overall magnitude of the rates diminished between 1987 and 1993. The changing role of TURP in detecting prostate cancer is attributed to changes in medical technology and screening practices. The declining influence of TURP on prostate cancer incidence is likely to have continued beyond the study period due to the recent introduction and increasing use of medications for treating obstructive uropathy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10522656     DOI: 10.1093/oxfordjournals.aje.a010090

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  15 in total

Review 1.  The effect of the USPSTF PSA screening recommendation on prostate cancer incidence patterns in the USA.

Authors:  Katherine Fleshner; Sigrid V Carlsson; Monique J Roobol
Journal:  Nat Rev Urol       Date:  2016-12-20       Impact factor: 14.432

Review 2.  Prostate cancer epidemiology in the United States.

Authors:  Otis W Brawley
Journal:  World J Urol       Date:  2012-04-05       Impact factor: 4.226

3.  Trends in the Incidence of Fatal Prostate Cancer in the United States by Race.

Authors:  Scott P Kelly; Philip S Rosenberg; William F Anderson; Gabriella Andreotti; Naji Younes; Sean D Cleary; Michael B Cook
Journal:  Eur Urol       Date:  2016-07-27       Impact factor: 20.096

4.  Trends in prostate cancer in the United States.

Authors:  Otis W Brawley
Journal:  J Natl Cancer Inst Monogr       Date:  2012-12

5.  Five-year downstream outcomes following prostate-specific antigen screening in older men.

Authors:  Louise C Walter; Kathy Z Fung; Katharine A Kirby; Ying Shi; Roxanne Espaldon; Sarah O'Brien; Stephen J Freedland; Adam A Powell; Richard M Hoffman
Journal:  JAMA Intern Med       Date:  2013-05-27       Impact factor: 21.873

6.  Stage-specific cancer incidence: an artificially mixed multinomial logit model.

Authors:  Solomon Chefo; Alex Tsodikov
Journal:  Stat Med       Date:  2009-07-10       Impact factor: 2.373

7.  Trends in prostate cancer incidence and mortality in Canada during the era of prostate-specific antigen screening.

Authors:  James Dickinson; Amanda Shane; Marcello Tonelli; Sarah Connor Gorber; Michel Joffres; Harminder Singh; Neil Bell
Journal:  CMAJ Open       Date:  2016-03-02

8.  Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005.

Authors:  H Gilbert Welch; Peter C Albertsen
Journal:  J Natl Cancer Inst       Date:  2009-08-31       Impact factor: 13.506

Review 9.  Symptomatic diagnosis of prostate cancer in primary care: a structured review.

Authors:  William Hamilton; Deborah Sharp
Journal:  Br J Gen Pract       Date:  2004-08       Impact factor: 5.386

10.  False-positive screening results in the Finnish prostate cancer screening trial.

Authors:  T P Kilpeläinen; T L J Tammela; L Määttänen; P Kujala; U-H Stenman; M Ala-Opas; T J Murtola; A Auvinen
Journal:  Br J Cancer       Date:  2010-01-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.